Skip to search formSkip to main contentSkip to account menu

GPX-150

Known as: Anthracycline Analogue GPX-150 
A synthetic non-cardiotoxic analogue of the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Anthracycline analogue GPX… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

5-imino-13-deoxydoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A phase 2 trial of 5-imino-13-deoxydoxorubicin (GPX-150) in metastatic and non-resectable soft tissue sarcomas.
11019Background: 5-imino-13-deoxydoxorubicin (GPX-150) is a doxorubicin (dox) analog that has been modified to retain the ability… 
2016
2016
Investigational Sarcoma Drug GPX-150 Gets Orphan Drug Designation
The FDA granted orphan drug designation for a developmental agent known as GPX-150, an analog of doxorubicin currently being… 
2005
2005
Immunomodulatory Properties of the Novel Anthracycline Analog, GPX-150: Implications for the Treatment of Chronic Inflammatory Disease
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)